Adcetris Delivers Post-Transplant Benefit in Relapsed Hodgkin Lymphoma
December 9th 2014Following treatment with high-dose chemotherapy and stem cell transplant, patients with relapsed and difficult-to-treat Hodgkin lymphoma who received Adcetris had a higher likelihood of progression-free survival at two years.